CHARLES D EBERT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES D EBERT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES D EBERT. CHARLES D EBERT is a Sr. VP, Research & Development in Actavis, Inc. ($ACT) and a SVP, BRANDS R&D in Allergan plc ($AGN).
Address: MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY 07054 NJ
Companies in which CHARLES D EBERT is an Insider
Allergan Finance LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES D EBERT: Sr. VP, Research & Development
Holdings: 0 shares
Latest Transaction: Oct 02 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Allergan plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES D EBERT: SVP, BRANDS R&D
Holdings: 18,488 shares
Current Value: $4,334,142
Latest Transaction: Oct 03 2013
$AGN Market Capitalization: $87.25B
$AGN Previous Close: $234.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CHARLES D EBERT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2013 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | D | 0.00 | 18,488 | 0 | 0 | 18.5 K to 0 (-100.00 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 144.00 | 13,694 | 1,971,936 | 18,488 | 32.2 K to 18.5 K (-42.55 %) |
| Oct 02 2013 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Grant | A | 0.00 | 12,212 | 0 | 32,182 | 20 K to 32.2 K (+61.15 %) |
| Oct 03 2013 | AGN | Allergan plc | EBERT CHARLES D | SVP, BRANDS R&D | Grant | A | 0.00 | 18,488 | 0 | 18,488 | 0 to 18.5 K |
| Aug 06 2013 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 136.25 | 8,244 | 1,123,246 | 19,970 | 28.2 K to 20 K (-29.22 %) |
| Mar 08 2013 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Grant | A | 0.00 | 1,727 | 0 | 28,214 | 26.5 K to 28.2 K (+6.52 %) |
| Mar 08 2013 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Grant | A | 0.00 | 2,653 | 0 | 26,487 | 23.8 K to 26.5 K (+11.13 %) |